Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 11, 2010 - Issue 18
Submit an article Journal homepage
199
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Nilotinib for the treatment of Philadelphia-chromosome-positive chronic myeloid leukemia

Amber Fullmer The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA +1 713 792 4764; +1 713 794 4297; [email protected]
,
Hagop Kantarjian The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA +1 713 792 4764; +1 713 794 4297; [email protected]
,
Jorge Cortes The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA +1 713 792 4764; +1 713 794 4297; [email protected]
&
Elias Jabbour The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA +1 713 792 4764; +1 713 794 4297; [email protected]
, MD
Pages 3065-3072 | Published online: 13 Nov 2010

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Francesca Musumeci, Silvia Schenone, Giancarlo Grossi, Chiara Brullo & Monica Sanna. (2015) Analogs, formulations and derivatives of imatinib: a patent review. Expert Opinion on Therapeutic Patents 25:12, pages 1411-1421.
Read now
Elias J Jabbour, Jorge E Cortes & Hagop M Kantarjian. (2013) Tyrosine kinase inhibition: a therapeutic target for the management of chronic-phase chronic myeloid leukemia. Expert Review of Anticancer Therapy 13:12, pages 1433-1452.
Read now

Articles from other publishers (2)

Francis J. Giles, Ophelia Q. P. Yin, William M. Sallas, Philipp D. le Coutre, Richard C. Woodman, Oliver G. Ottmann, Michele Baccarani & Hagop M. Kantarjian. (2012) Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia. European Journal of Clinical Pharmacology 69:4, pages 813-823.
Crossref
Mary Alikian, Gareth Gerrard, Papagudi G. Subramanian, Katherine Mudge, Pierre Foskett, Jamshid Sorouri Khorashad, Ai Chiin Lim, David Marin, Dragana Milojkovic, Alistair Reid, Katy Rezvani, John Goldman, Jane Apperley & Letizia Foroni. (2012) BCR‐ABL1 kinase domain mutations: Methodology and clinical evaluation . American Journal of Hematology 87:3, pages 298-304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.